Monocyte-platelet function and protection against cardiovascular disease

Maturitas

Volumn 23, Issue SUPPL., 1996, Pages

  Øian, Pål ^a   Østerud, Bjarne ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Atherosclerosis; Hormone replacement therapy; Thrombosis; Thromboxane; Tissue factor; Tumor necrosis factor

Indexed keywords

THROMBOPLASTIN; THROMBOXANE; TUMOR NECROSIS FACTOR ALPHA;

ATHEROSCLEROSIS; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; DOWN REGULATION; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; LIPID METABOLISM; LIPOPROTEIN METABOLISM; REVIEW; RISK FACTOR; THROMBOCYTE FUNCTION; THROMBOGENESIS;

THROMBUS;

EID: 0029780276     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5122(96)01013-4     Document Type: Review

References (14)

1. Sullivan JM, Vanderzwaag R, Lemp G et al. Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women. Ann Intern Med 1988; 108: 358-63.
2. Barret-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA 1991; 265: 1861-7.
3. Godsland I, Gangar K, Walton C et al. Insulin resistance, secretion and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy. Metabolism 1993; 42: 846-53.
4. Collins P, Rosano GM, Jiang C et al. Cardiovascular protection by oestrogen - a calcium antagonist effect? Lancet 1993; 341: 1264-5.
5. Schwartz CJ, Valente AJ, Sprague EA. A modern view of atherogenesis. Am J Cardiol 1993; 71: 9B-14B.
6. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86: 2839-45.
7. Østerud B. The high responder phenomenon: Enhancement of LPS induced tissue factor activity in monocytes by platelets and granulocytes. Platelets 1995; 6: 119-25.
8. Øian P, Omsjø I, Maltau JM, østerud B. Reduced thromboplastin activity in blood monocytes and reduced sensitivity to stimuli in-vitro of blood monocytes from normal pregnant women. Br J Haematol 1985; 59:133-7.
9. Aune B, Øian P, Østerud B. Enhanced sensitivity of the extrinsic coagulation system during ovarian stimulation for in-vitro fertilization. Human Reprod 1993; 8: 1349-52.
10. Aune B, Øian P, Omsjø I, Østerud B. Hormone replacement therapy reduces the reactivity of monocytes and platelets in whole blood - A beneficial effect on atherogenesis and thrombus formation? Am J Obstet Gynecol 1995; 173: 1816-20.
11. Bareth P, Fisbein MC, Cao J et al. Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol 1990; 65: 297-302.
12. Ross R. Atherosclerosis: A defense mechanism gone awry. Am J Pathol 1993; 143: 987-1002.
13. Balteskard L, Brox JH, Østerud B. Thromboxane production in the blood of women increases after menopause whereas tumor necrosis factor is reduced in women compared to men. Atherosclerosis 1993; 102: 91-8.
14. Østerud B, Elvevoll K, Barstad H et al. Effect of marine oils supplementation on coagulation and cellular activation in whole blood. Lipids 1995; 30: 1111-18.